TerminatedNCT06972745

Efficacy & Tolerability of Rigth Unilateral vs. Bitemporal ECT in Schizophrenia in a Psychiatric Hospital in Mexico

Interventional studyAges 18+Mexico

The study in practice

Understand this study

This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: March 16, 2023

Recruitment status: Terminated
Enrollment listed in the registry: 17
Sponsor: Hospital Psiquiátrico Fray Bernardino Álvarez
Sponsor type: Hospital / academic medical center
Study type: Procedure
Intervention type: PROCEDURE
Study phase: Not clearly listed
Locations: Mexico
Age range: Over 18 Years
Official registry ID: NCT06972745
Official title: Show the full official title
Cohort Study on Efficacy and Tolerance of Right Unilateral Electroconvulsive Therapy vs. Bitemporal in Patients With Paranoid Schizophrenia in Acute Psychosis at Fray Bernardino Álvarez Psychiatric Hospital

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Terminated

México

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Hospital Psiquiátrico Fray Bernardino Álvarez, a hospital or academic medical center.

Who can participate?

This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.